U3 Pharma GmbH clinical trials
Acquired by Daiichi Sankyo
The registry lists 1 studies whose lead sponsor is U3 Pharma GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 29, 2010.
Registry sponsor names on this page
- U3 Pharma GmbH1 study
Something wrong with this grouping? Tell us on the Daiichi Sankyo page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Daiichi Sankyo studies →
- Phase I Study of U3P1287/01, Including Patients With Advanced Solid TumorsCompletedNCT00730470Phase 1
Sponsor listed in the registry: U3 Pharma GmbH · U3 Pharma GmbH — acquired company within the Daiichi Sankyo group